Literature DB >> 16644726

Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.

Jinghua Xu1, Barbara Christian, Donald B Jump.   

Abstract

Carbohydrate regulatory element-binding protein (ChREBP), MAX-like factor X (MLX), and hepatic nuclear factor-4alpha (HNF-4alpha) are key transcription factors involved in the glucose-mediated induction of hepatic L-type pyruvate kinase (L-PK) gene transcription. n-3 polyunsaturated fatty acids (PUFA) and WY14643 (peroxisome proliferator-activated receptor alpha (PPARalpha) agonist) interfere with glucose-stimulated L-PK gene transcription in vivo and in rat primary hepatocytes. Feeding rats a diet containing n-3 PUFA or WY14643 suppressed hepatic mRNA(L-PK) but did not suppress hepatic ChREBP or HNF-4alpha nuclear abundance. Hepatic MLX nuclear abundance, however, was suppressed by n-3 PUFA but not WY14643. In rat primary hepatocytes, glucose-stimulated accumulation of mRNA(LPK) and L-PK promoter activity correlated with increased ChREBP nuclear abundance. This treatment also increased L-PK promoter occupancy by RNA polymerase II (RNA pol II), acetylated histone H3 (Ac-H3), and acetylated histone H4 (Ac-H4) but did not significantly impact L-PK promoter occupancy by ChREBP or HNF-4alpha. Inhibition of L-PK promoter activity by n-3 PUFA correlated with suppressed RNA pol II, Ac-H3, and Ac-H4 occupancy on the L-PK promoter. Although n-3 PUFA transiently suppressed ChREBP and MLX nuclear abundance, this treatment did not impact ChREBP-LPK promoter interaction. HNF4alpha-LPK promoter interaction was transiently suppressed by n-3 PUFA. Inhibition of L-PK promoter activity by WY14643 correlated with a transient decline in ChREBP nuclear abundance and decreased Ac-H4 interaction with the L-PK promoter. WY14643, however, had no impact on MLX nuclear abundance or HNF4alpha-LPK promoter interaction. Although overexpressed ChREBP or HNF-4alpha did not relieve n-3 PUFA suppression of L-PK gene expression, overexpressed MLX fully abrogated n-3 PUFA suppression of L-PK promoter activity and mRNA(L-PK) abundance. Overexpressed ChREBP, but not MLX, relieved the WY14643 inhibition of L-PK. In conclusion, n-3 PUFA and WY14643/PPARalpha target different transcription factors to control L-PK gene transcription. MLX, the heterodimer partner for ChREBP, has emerged as a novel target for n-3 PUFA regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644726      PMCID: PMC2766394          DOI: 10.1074/jbc.M601277200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?

Authors:  Zafar Nawaz; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2003-12-12

2.  Selective proteolytic processing of rat hepatic sterol regulatory element binding protein-1 (SREBP-1) and SREBP-2 during postnatal development.

Authors:  Daniela Botolin; Donald B Jump
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

3.  Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

Authors:  Zhigang Kang; Asta Pirskanen; Olli A Jänne; Jorma J Palvimo
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

Review 4.  Fatty acid regulation of gene transcription.

Authors:  Donald B Jump
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

5.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis.

Authors:  Katsumi Iizuka; Richard K Bruick; Guosheng Liang; Jay D Horton; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

6.  The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.

Authors:  Anjali Pawar; Daniela Botolin; David J Mangelsdorf; Donald B Jump
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

7.  Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes.

Authors:  Anjali Pawar; Donald B Jump
Journal:  J Biol Chem       Date:  2003-07-09       Impact factor: 5.157

8.  AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability.

Authors:  Yu Holly Hong; Usha S Varanasi; Wenbo Yang; Todd Leff
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

9.  Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes.

Authors:  Angela K Stoeckman; Lin Ma; Howard C Towle
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

10.  Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene.

Authors:  E G Beale; N B Chrapkiewicz; H A Scoble; R J Metz; D P Quick; R L Noble; J E Donelson; K Biemann; D K Granner
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

View more
  26 in total

Review 1.  Metabolic regulation of histone post-translational modifications.

Authors:  Jing Fan; Kimberly A Krautkramer; Jessica L Feldman; John M Denu
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

Review 2.  Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

3.  High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.

Authors:  Joshua S Wooten; Tayler N Nick; Andrew Seija; Kaylee E Poole; Kelsey B Stout
Journal:  J Clin Exp Hepatol       Date:  2016-09-08

4.  Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins.

Authors:  Jessica L Feldman; Josue Baeza; John M Denu
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

Review 5.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 6.  Fatty acid-regulated transcription factors in the liver.

Authors:  Donald B Jump; Sasmita Tripathy; Christopher M Depner
Journal:  Annu Rev Nutr       Date:  2013-03-22       Impact factor: 11.848

Review 7.  Docosahexaenoic acid (DHA) and hepatic gene transcription.

Authors:  Donald B Jump; Daniela Botolin; Yun Wang; Jinghua Xu; Olivier Demeure; Barbara Christian
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

8.  Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.

Authors:  Nestor W Meza; Maria E Alonso-Ferrero; Susana Navarro; Oscar Quintana-Bustamante; Antonio Valeri; Maria Garcia-Gomez; Juan A Bueren; Jose M Bautista; Jose C Segovia
Journal:  Mol Ther       Date:  2009-09-15       Impact factor: 11.454

Review 9.  Vitamin E, antioxidant and nothing more.

Authors:  Maret G Traber; Jeffrey Atkinson
Journal:  Free Radic Biol Med       Date:  2007-03-31       Impact factor: 7.376

10.  A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids.

Authors:  Alison B Kohan; Indrani Talukdar; Callee M Walsh; Lisa M Salati
Journal:  Biochem Biophys Res Commun       Date:  2009-07-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.